Cargando…

Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype

Background: Vitamin K antagonists (VKA) are known to promote adverse cardiovascular remodeling. Contrarily, vitamin K supplementation has been discussed to decelerate cardiovascular disease. The recently described VKOR-isoenzyme Vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) is invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksoy, Adem, Al Zaidi, Muntadher, Repges, Elena, Becher, Marc Ulrich, Müller, Cornelius, Oldenburg, Johannes, Zimmer, Sebastian, Nickenig, Georg, Tiyerili, Vedat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578699/ https://www.ncbi.nlm.nih.gov/pubmed/34778390 http://dx.doi.org/10.3389/fcvm.2021.708946

Ejemplares similares

ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling
por: Al Zaidi, Muntadher, et al.
Publicado: (2022)

VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
por: Oldenburg, Johannes, et al.
Publicado: (2015)

Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1(−/−) LDLr(−/−) double knockout mice
por: Jehle, Julian, et al.
Publicado: (2017)

Propensity-score-matched comparison of safety, efficacy, and outcome of intravascular lithotripsy versus high-pressure PTCA in coronary calcified lesions
por: Aksoy, Adem, et al.
Publicado: (2021)

AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ
por: Tiyerili, Vedat, et al.
Publicado: (2013)

Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains
por: Song, Ying, et al.
Publicado: (2008)

Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
por: Al Zaidi, Muntadher, et al.
Publicado: (2023)

Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice
por: Tiyerili, Vedat, et al.
Publicado: (2015)

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations()
por: Matagrin, Benjamin, et al.
Publicado: (2013)

Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity
por: Janssen, Rob, et al.
Publicado: (2020)

Hospital admissions during Covid-19 lock-down in Germany: Differences in discretionary and unavoidable cardiovascular events
por: Stöhr, Elisabeth, et al.
Publicado: (2020)

Atheroprotective effects of 17β-oestradiol are mediated by peroxisome proliferator-activated receptor γ in human coronary artery smooth muscle cells
por: Jehle, Julian, et al.
Publicado: (2020)

Structural Modeling Insights into Human VKORC1 Phenotypes
por: Czogalla, Katrin J., et al.
Publicado: (2015)

CHA(2)DS(2)-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
por: Kavsur, Refik, et al.
Publicado: (2021)

Personalized cardiac regeneration by stem cells–Hype or hope?
por: Becher, Ulrich Marc, et al.
Publicado: (2011)

Variation in VKORC1 Is Associated with Vascular Dementia
por: Mur, Jure, et al.
Publicado: (2021)

VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation
por: Marinova, Milka, et al.
Publicado: (2012)

A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens
por: Öztürk, Can, et al.
Publicado: (2021)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

GGCX and VKORC1 inhibit osteocalcin endocrine functions
por: Ferron, Mathieu, et al.
Publicado: (2015)

Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
por: Tanaka, Tetsu, et al.
Publicado: (2021)

The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation
por: Öztürk, Can, et al.
Publicado: (2020)

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
por: Anton, Ana Isabel, et al.
Publicado: (2013)

VKORC1 variants as significant predictors of warfarin dose in Emiratis
por: Al-Mahayri, Zeina N, et al.
Publicado: (2019)

Correction: GGCX and VKORC1 inhibit osteocalcin endocrine functions
por: Ferron, Mathieu, et al.
Publicado: (2019)

Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population
por: Kumar, Dhakchinamoorthi Krishna, et al.
Publicado: (2013)

Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement
por: Kaur, Anupriya, et al.
Publicado: (2013)

Missense mutation of VKORC1 leads to medial arterial calcification in rats
por: Michaux, Arnaud, et al.
Publicado: (2018)

3D-speckle-tracking echocardiography correlates with cardiovascular magnetic resonance imaging diagnosis of acute myocarditis – An observational study
por: Goody, Philip Roger, et al.
Publicado: (2022)

VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues
por: Lacombe, Julie, et al.
Publicado: (2018)

Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction
por: Andrié, René P, et al.
Publicado: (2012)

Novel mutations in the VKORC1 gene of wild rats and mice – a response to 50 years of selection pressure by warfarin?
por: Rost, Simone, et al.
Publicado: (2009)

Methylation of CYP1A1 and VKORC1 promoter associated with stable dosage of warfarin in Chinese patients
por: He, Shiwei, et al.
Publicado: (2021)

Analysis of vkorc1 polymorphisms in Norway rats using the roof rat as outgroup
por: Díaz, Juan C, et al.
Publicado: (2010)

Association of Warfarin Therapy with APOE and VKORC1 Genes Polymorphism in Iranian Population
por: Rafiee, Sajad, et al.
Publicado: (2017)

Polymorphism of the CYP2C9 and VKORC1 genes: a comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Investigation of anticoagulant rodenticide resistance induced by Vkorc1 mutations in rodents in Lebanon
por: Rached, Antoine, et al.
Publicado: (2022)

Vkorc1 gene polymorphisms confer resistance to anticoagulant rodenticide in Turkish rats
por: Yiğit, Nuri, et al.
Publicado: (2023)

Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome
por: Jehle, Julian, et al.
Publicado: (2019)

Distribution of anticoagulant rodenticide resistance in Rattus norvegicus in the Netherlands according to Vkorc1 mutations
por: Meerburg, Bastiaan G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n7lemvvic7t0bbq3m80cbmf47o